Thomas L. Tran, Former Chief Financial Officer of Molina Healthcare, Joins Clover Health’s Board of Directors
Clover Health (NASDAQ: CLOV) has appointed Thomas L. Tran to its Board of Directors and Audit Committee. Tran, with over 35 years of financial leadership in healthcare, most recently served as CFO of Upstream Care and previously as CFO of Molina Healthcare. CEO Andrew Toy highlighted Tran's expertise in strategic financial planning for public managed care organizations as a significant asset for Clover's mission of empowering physicians and improving health outcomes through technology. Tran expressed enthusiasm for Clover's innovative approach to Medicare and value-based care, stating his commitment to helping shape the company's vision.
Clover Health (NASDAQ: CLOV) ha nominato Thomas L. Tran nel suo Consiglio di Amministrazione e nel Comitato di Revisione. Tran, con oltre 35 anni di esperienza nella leadership finanziaria in ambito sanitario, ha recentemente ricoperto il ruolo di CFO presso Upstream Care e in precedenza è stato CFO di Molina Healthcare. Il CEO Andrew Toy ha sottolineato l'esperienza di Tran nella pianificazione finanziaria strategica per le organizzazioni di assistenza gestita pubblica come un asset significativo per la missione di Clover di potenziare i medici e migliorare i risultati sanitari attraverso la tecnologia. Tran ha espresso entusiasmo per l'approccio innovativo di Clover a Medicare e alla cura basata sul valore, dichiarando il suo impegno a contribuire a definire la visione dell'azienda.
Clover Health (NASDAQ: CLOV) ha nombrado a Thomas L. Tran en su Junta Directiva y en el Comité de Auditoría. Tran, con más de 35 años de liderazgo financiero en el sector de la salud, desempeñó recientemente el cargo de CFO en Upstream Care y anteriormente fue CFO de Molina Healthcare. El CEO Andrew Toy destacó la experiencia de Tran en la planificación financiera estratégica para organizaciones de atención administrada pública como un activo importante para la misión de Clover de empoderar a los médicos y mejorar los resultados de salud a través de la tecnología. Tran expresó su entusiasmo por el enfoque innovador de Clover hacia Medicare y la atención basada en el valor, afirmando su compromiso de ayudar a dar forma a la visión de la empresa.
Clover Health (NASDAQ: CLOV)가 Thomas L. Tran을 이사회 및 감사위원회에 임명했습니다. Tran은 35년 이상의 헬스케어 분야 재무 리더십 경력을 가지고 있으며, 최근에는 Upstream Care의 CFO로 재직했고 그 이전에는 Molina Healthcare의 CFO를 역임했습니다. CEO Andrew Toy는 Tran의 공공 관리 서비스 조직을 위한 전략적 재무 계획에 대한 전문 지식이 Clover의 의사 역량 강화 및 기술을 통한 건강 결과 개선이라는 미션에 큰 자산이 된다고 강조했습니다. Tran은 Clover의 Medicare 및 가치 기반 치료에 대한 혁신적인 접근법에 대한 열정을 표현하며 회사 비전을 형성하는 데 기여할 것을 다짐했습니다.
Clover Health (NASDAQ: CLOV) a nommé Thomas L. Tran à son conseil d'administration et à son comité d'audit. Tran, fort de plus de 35 ans de leadership financier dans le secteur de la santé, a récemment été CFO d'Upstream Care et auparavant CFO de Molina Healthcare. Le CEO Andrew Toy a souligné l'expertise de Tran en matière de planification financière stratégique pour les organisations publiques de soins gérés comme un atout majeur pour la mission de Clover de renforcer les médecins et d'améliorer les résultats de santé grâce à la technologie. Tran a exprimé son enthousiasme pour l'approche innovante de Clover en matière de Medicare et de soins basés sur la valeur, affirmant son engagement à contribuer à façonner la vision de l'entreprise.
Clover Health (NASDAQ: CLOV) hat Thomas L. Tran in seinen Vorstand und den Prüfungsausschuss berufen. Tran bringt über 35 Jahre Erfahrung in finanzieller Führung im Gesundheitswesen mit, zuletzt als CFO von Upstream Care und zuvor als CFO von Molina Healthcare. CEO Andrew Toy hob Trans Expertise in strategischer Finanzplanung für öffentliche Managed Care-Organisationen als erhebliches Asset für die Mission von Clover hervor, die Ärzte zu stärken und die Gesundheitsergebnisse durch Technologie zu verbessern. Tran zeigte sich begeistert von Chlovers innovativem Ansatz für Medicare und wertbasierte Versorgung und erklärte sein Engagement, zur Gestaltung der Unternehmensvision beizutragen.
- Appointment of Thomas L. Tran, an experienced healthcare finance leader, to the Board of Directors
- Enhancement of strategic financial planning capabilities with Tran's expertise in public managed care organizations
- Strengthening of the Audit Committee with Tran's addition
- None.
FRANKLIN, Tenn., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced it has appointed Thomas L. Tran to the Company’s Board of Directors (the "Board"), and as a member of the Audit Committee.
“Tom Tran’s appointment to our Board marks a significant enhancement to our strategic financial planning and execution capabilities. With his impressive track record at the helm of finance at public managed care organizations, Tom is uniquely qualified to help guide Clover Health as we advance our mission of empowering physicians and improving health outcomes through innovative technology,” said Andrew Toy, Chief Executive Officer of Clover Health.
Mr. Tran has over 35 years of financial leadership experience in the healthcare industry and has previously held leadership roles at various prominent managed care companies. Most recently, from February 2022 to June 2023, Mr. Tran served as chief financial officer and as a director of Upstream Care, a value-based physician enablement innovator focused on the Medicare population. From June 2018 to May 2021, he served as chief financial officer of Molina Healthcare, Inc. Mr. Tran earned his Bachelor’s degree from Seton Hall University and his Master of Business Administration degree from New York University.
“Having dedicated my career to improving healthcare through better financial and operational strategies, I find Clover Health's mission very compelling. I believe Clover’s innovative use of technology to drive better health outcomes represents the future of Medicare. I am excited to join the Board and help shape this vision, ensuring Clover continues to lead in value-based care,” said Mr. Tran.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we aim to extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Press Contact:
Andrew Still-Baxter
press@cloverhealth.com
Investor Relations Contact:
Ryan Schmidt
investors@cloverhealth.com
FAQ
Who is the new Board member appointed to Clover Health (CLOV)?
What is Thomas L. Tran's background and experience relevant to Clover Health (CLOV)?
How might Thomas L. Tran's appointment impact Clover Health's (CLOV) future strategy?
When did Thomas L. Tran join Clover Health's (CLOV) Board of Directors?
